Viewing StudyNCT00239239



Ignite Creation Date: 2024-05-05 @ 12:05 PM
Last Modification Date: 2024-10-26 @ 9:20 AM
Study NCT ID: NCT00239239
Status: COMPLETED
Last Update Posted: 2010-03-05
First Post: 2005-10-13

Brief Title: Fractionated Dosing Study Study to Evaluate Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies
Sponsor: Amgen
Organization: Amgen

Organization Data

Organization: Amgen
Class: INDUSTRY
Study ID: 20040232
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Amgen
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: Global Development Leader
Old Organization: Amgen Inc

Collaborators